Dr. Xavier Santamaria
Xavier Santamaria M.D, Ph.D. is a specialist obstetrician and gynecologist in Reproductive Medicine working as a clinician at IVI Valencia from 2010 to 2012 and IVI Barcelona from 2012 to 2020. He was Head of Equipo IVI International Department Area from 2012 until July 2016.
He has lately focused his work on the field of biomedical research research to investigate in the Asherman’s Sydrome at Igenomix besides his research projects in Endometriosis and Liquid Biopsy as Biomedical Investigator in Gynecology at the Vall d’Hebron Research Institute. With his team he is developing an new therapeutic approach to treat Asherman Syndrome and he has obtained for the first time the Orphan Drug Designation of the EMA (European Medicines Agency) and FDA (Food and Drug Administration) for stem cell therapy in this pathology.
On graduation as Medical Doctor in 2003, he was board certified in obstetrics and gynecology at the Hospital del Mar (Barcelona) in 2008 and completed a Doctoral Degree at the Universitat Autònoma of Barcelona in 2013. While preparing his PhD, he obtained a post-graduate fellowship on Reproductive Endocrinology and Infertility at Yale University (2008-2010) at Dr Hugh Taylor’s Lab.
Among his large post-graduate training, he performed Laparoscopic Surgery Fellowship under the supervision of Professor Querleu at the Institute Claudius Regaud - Toulouse (France) and he has recently has obtained the ESHRE Reproductive Surgery Certificate. He also improved his research skills at The Frontiers in Reproduction Course at the Marine Biological Laboratory - Woods Hole (USA) in 2008.
Dr. Santamaría was awarded with the Prize as Best Oral Presentation for Young Investigators at the Society of Gynecological Investigation Meeting (2009), CajaMadrid Post Graduate Grant (2008), Burroughs Wellcome Fund (2008) and has raised fundings for research from CDTI (Centro Desarrollo Tecnico Industrial) . He is main author of more than 20 articles in the international journals, 11 chapters in books and invited speaker in more than 80 international conferences and he is currently member of the European Society for Human Reproduction and Embryology (ESHRE) and of the Spanish Fertility Society (SEF).